Get recipes, tips and all kinds of cheezy goodness
delivered right to your inbox.
Posted on January 19, 2018
Daiya Foods Inc., an indirect subsidiary of Otsuka Holdings Co., Ltd., announces that the latter has signed the CEO Statement of Support for the Women’s Empowerment Principles (WEPs), a set of Principles focusing on corporate action to promote gender equality and women’s empowerment in the workplace, marketplace and community. The WEPs are the result of collaboration between the United Nations Global Compact (UNGC) 1 and the United Nations Entity for Gender Equality and the Empowerment of Women (UN Women).2
Under the corporate philosophy of “Otsuka-people creating new products for better health worldwide,” the Otsuka group of companies is a total health care group active on the global stage. Convinced that maximizing the talents of a diverse group of individuals becomes the driving force for growth, Otsuka promotes diversity across the group companies, including proactively encouraging the participation and advancement of women in the workplace. The signing of the CEO Statement of Support for the WEPs is an opportunity to reinforce efforts to ensure gender equality and women’s empowerment.
The Women’s Empowerment Principles are a set of voluntary principles offering guidance for corporate practices to promote equality and women’s empowerment, launched in 2010 as the result of collaboration between the UNGC and UN Women. By signing the CEO Statement of Support for the WEPs, a company demonstrates its dedication to contributing to workplace, marketplace and community environments that encourage advancement and empowerment of women. The seven Women’s Empowerment Principles are listed below.3
About Otsuka Holdings Co., Ltd.
Otsuka Holdings Co., Ltd. is the holding company for the Otsuka group of companies, a global healthcare group headquartered in Tokyo, Japan. With operations in pharmaceuticals, nutraceuticals, medical devices and other health-related businesses, the group generated worldwide sales of approximately USD 10.2 billion in the fiscal year ended December 31, 2016.
The Otsuka group of companies conducts research, development, manufacturing and marketing of innovative products that are uniquely positioned to provide advanced therapy, improve quality of life and support a healthy lifestyle. Additional information can be obtained at https://www.otsuka.com/en/
References: